Clinical trials sponsored by Fujian Provincial Hospital

Phase breakdown

Conditions studied

Recruiting trials led by Fujian Provincial Hospital

• D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC
  NCT06643208 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older Adults
  NCT06717828 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 75 Years · Sex: All (male and female) · 1 location
• mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer
  NCT06761027 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 4 locations

Common questions

How many trials is Fujian Provincial Hospital recruiting for?

Fujian Provincial Hospital is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.